bonyf NV · ISIN: BE6333353298 · EQS - Company News

bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India

bonyf NV / Key word(s): Alliance/Agreement bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India 28-Nov-2024 / 11:20 CET/CEST bonyf expands its global NitrAdine® formulation footprint through its latest strategic alliance achievement with Group Pharmaceuticals Ltd, by a license agreement to produce NitrAdine® denture cleansing and disinfecting tablets for I...

EURONEXT:MLBON Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News bonyf NV

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
28 November 2024 11:20AM
bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India
BE6333353298
bonyf NV / Key word(s): Alliance/Agreement bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India 28-Nov-2024 / 11:20 CET/CEST bonyf expands its global NitrAdine® formulation footprint through its latest strate...
bonyf NV
About the publication
24 October 2024 11:48AM
PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care
BE6333353298
bonyf NV / Key word(s): Product Launch/Research Update PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care 24-Oct-2024 / 11:48 CET/CEST PerioTabs®: Innovative 10-Day NitrAdine®-Based Treatment to Revolutionize Oral Care Effervescent tablet offers a unique approach to treating gum and impla...
bonyf NV
About the publication
More bonyf NV related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN